HLscience Co. Ltd (239610) Fair Value & Analysis
Healthcare · KR · Market cap 27.7B KRW
Risks
Fair value as of: Aug 13, 2026
From 1 valuation models · updated 7 days ago
Share price +1.5% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range (3,887 KRW to 7,361 KRW) leaves room in how you read the outcome.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 5,090 KRW – 43,742 KRW · fair‑value band 3,887 KRW – 7,361 KRW · the 5,520 KRW price screens below the 5,889 KRW fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
HLscience Co. Ltd (239610) currently trades at 5,520 KRW, while our model-based Fair Value estimate is 5,889 KRW, implying the stock looks roughly 6.7% fairly valued today. The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, HLscience Co. Ltd generated revenue of 13.8B KRW at a net margin of -82.1%. Revenue declined 58.0% year over year. It earns a return on equity of -13.1%. Fundamentals as of Aug 13, 2026
Our scenario range runs from 3,887 KRW (bear case) to 7,361 KRW (bull case); at 5,520 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 60% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -40% fair-value upside, at 7%, 239610 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 239610 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 44 · Market factors (momentum, volatility) 22
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr.
Full company description
HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiotics Plus. It also provides CDMO, contract development organization and contract research organization, contract manufacturing organization, quality assurance system, and funding services. Its products are used for antioxidant/skin health/immune function, female menopausal health/skin moisturizing/UV care, liver health, cartilage and joint health/bone health, body fat reduction/energy metabolism, brain health/blood circulation improvement, and gut health applications. The company was founded in 2000 and is headquartered in Hwaseong-si, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
HLscience Co. Ltd reported revenue of 16.7B KRW in FY2025 versus 104B KRW in FY2021, a compound −36.7%/yr. Reported net income was −11.9B KRW in FY2025.
Watch 239610: get an alert when its fair value changes →
Peer Group
Drug Manufacturers - Specialty & Generic · 638 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$56.05 | HK$33.59 | -40% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,944 | ₹989.50 | -49% |
| Divi's Laboratories Limited DIVISLAB | ₹8,525 | ₹1,228 | -86% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,915 | ₹1,163 | -76% |
| PharmaEssentia Corporation 6446 | 1,440 TWD | 233.93 TWD | -84% |
| Cipla Limited CIPLA | ₹1,463 | ₹1,001 | -32% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,167 | ₹703.32 | -40% |
| Lupin Limited LUPIN | ₹2,281 | ₹2,477 | +9% |
| Mankind Pharma Limited MANKIND | ₹2,433 | ₹983.11 | -60% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,200 | ₹874.79 | -27% |
Compare HLscience Co. Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is HLscience Co. Ltd (239610) overvalued or undervalued?
What is the fair value of 239610?
What is the quality score of 239610?
What is the revenue of HLscience Co. Ltd (239610)?
What is the net profit margin of 239610?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track HLscience Co. Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.